Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1110904

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1110904

Global Animal Medicine Market - By Type of Animal, By Type, By Type of Prescription, By Route of Administration, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

PUBLISHED:
PAGES: 224 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

According to SPER Market Research, the Animal Medicine global market is estimated to reach USD 54.97 billion by 2030 with a CAGR of 7.1%.

The industry for animal medicine consists of businesses that produce veterinary medicines such as veterinary vaccinations, veterinary antibiotics, and other veterinary pharmaceuticals, as well as businesses that provide medical feed additives and dietary feed additives.

Growing expanding markets, rising pet expenditures, rising illness prevalence, rising outbreaks of poultry diseases, and a lack of generic medications all contributed to expansion over the historical era. Lack of veterinarians, ignorance, incorrect medication usage, the expense of animal care, the rise in the use of fake vaccinations and medications, and strict laws all had a detrimental impact on development during that time.

The market for animal medicines is anticipated to be constrained by the growing concern of antibiotic resistance among animals. The capacity of a microorganism to survive the effects of an antibiotic that formerly could effectively treat an infection caused by the same kind of bacteria is known as antibiotic resistance in animals. Overuse of antibiotics may be the cause of this. China declared a ban on antibiotic usage in feeds starting in 2020 and a halt to the manufacturing of commercial feed containing pharmaceutical feed additives that promote growth as a response to the threat posed by antibiotic resistance.

Companies that produce veterinarian medicines are increasingly focused on super-combo parasiticide in the market for animal medicines. Before parasites damage animals, parasiticides are drugs that aid in their management. Companies invest in and produce combination parasiticides as a result of these products' greater efficiency and efficacy. Companies in the animal pharmaceutical industry are increasingly developing combination parasiticides that help treat fleas, heartworms, and common intestinal parasites more effectively.

Impact of COVID-19 on the Global Animal Medicine Market :

Each industry has been touched by COVID-19, without exception. The market for veterinary medications has also been impacted. The demand for veterinary vaccines has increased to some extent due to enhanced health facilities for animal husbandry and growing knowledge of immunization against illnesses that affect cattle. However, amid the veterinary vaccination crisis, major players, governmental agencies, and healthcare organizations are collaborating closely with medical experts, clients, and patients to improve animal health.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Type of Animal, By Type, By Type of Prescription, By Route of Administration, By Distribution Channel
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Animalcare, Agrovet Market Animal Health, BASF India Ltd., Bayer, Animal Health Cadila Vaccines Ltd., Bimeda, Boehringer Ingelheim GmbH, Ceva Sante Animale, Century Vaccines Limited, Chemo Argentina, DBK Pharma S.A.E., Elanco Animal Health Incorporated, HIPRA, IDT Biologika, Interfeed , Jurox Pty Ltd, Kyoritsu Seiyaku Corporation, Merck Animal Health, MSD Animal Health, Nimrod Veterinary Products Ltd., Novartis Animal Health, Phibro Animal Health Corporation, Sanofi Animal Health Inc., UCBVET, Virbac RSA, Zoetis India.

Global Animal Medicine Market, By Type of Animal:

Based on the Type of Animal, Global Animal Medicine Market is segmented as; Poultry, Cattle (Dairy and Meat Purposes) Dogs and Cats, Other Companion Animals, Other Farm Animals.

Global Animal Medicine Market, By Type:

Based on the Type, Global Animal Medicine Market is segmented as; Veterinary Pharmaceuticals (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides) Feed Additives (Medical Feed Additives, Nutritional Feed Additives).

Global Animal Medicine Market, By Type of Prescription:

Based on the Type of Prescription, Global Animal Medicine Market is segmented as; OTC, Prescription.

Global Animal Medicine Market, By Route of Administration:

Based on the Route of Administration, Global Animal Medicine Market is segmented as; Oral, Intravenous Subcutaneous, Others.

Global Animal Medicine Market, By Distribution Channel:

Based on the Distribution Channel, Global Animal Medicine Market is segmented as; Veterinary services, Online, Others.

Global Animal Medicine Market, By Region:

The Global Animal Medicine Market is majorly driven by North America. During the projected period, North America is anticipated to have the quickest rate of growth in the worldwide Global Animal Medicine Market.

Product Code: HLCA2205

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Animal Medicine Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Animal Medicine Market, By Type Of Animal, 2019-2030 (USD Million)

  • 6.1. Poultry
  • 6.2. Cattle (Dairy and Meat Purposes)
  • 6.3. Dogs and Cats
  • 6.4. Other Companion Animals
  • 6.5. Other Farm Animals

7. Global Animal Medicine Market, By Type, 2019-2030 (USD Million)

  • 7.1. Veterinary Pharmaceuticals
    • 7.1.1. Veterinary Vaccines
    • 7.1.2. Veterinary Antibiotics
    • 7.1.3. Veterinary Parasiticides
  • 7.2. Feed Additives
    • 7.2.1. Medical Feed Additives
    • 7.2.1. Nutritional Feed Additives

8. Global Animal Medicine Market, By Type of Prescription, 2019-2030 (USD Million)

  • 8.1. OTC
  • 8.2. Prescription

9. Global Animal Medicine Market, By Route of Administration, 2019-2030 (USD Million)

  • 9.1. Oral
  • 9.2. Intravenous
  • 9.3. Subcutaneous
  • 9.4. Others

10. Global Animal Medicine Market, By Distribution Channel, 2019-2030 (USD Million)

  • 10.1. Veterinary Services
  • 10.2. Online
  • 10.3. Others

11. Global Animal Medicine Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Animalcare
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Agrovet Market Animal Health
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. BASF India Ltd.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Bayer Animal Health Cadila Vaccines Ltd.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Bimeda
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Boehringer Ingelheim GmbH
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Ceva Sante Animale
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Century Vaccines Limited
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Chemo Argentina
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. DBK Pharma S.A.E.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Elanco Animal Health Incorporated
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. HIPRA
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. IDT Biologika
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Interfeed
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Jurox Pty Ltd
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent development
  • 12.16. Kyoritsu Seiyaku Corporation
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Merck Animal Health
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. MSD Animal Health
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. Nimrod Veterinary Products Ltd.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Novartis Animal Health
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. Phibro Animal Health Corporation
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Sanofi Animal Health Inc.
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. UCBVET
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. Virbac RSA
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25. Zoetis India
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent development
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!